ホーム › 脂肪肝 › カリフォルニア州

カリフォルニア州における脂肪肝の臨床試験

カリフォルニア州内の拠点で、脂肪肝に関する22件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト（英語）

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Folsom

被験者募集中第3相

18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Folsom

被験者募集中第3相

18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Southern California Research Center, Coronado
California Liver Research Institute, Pasadena

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

University of California San Diego NAFLD Research Center, La Jolla
Keck Medical Center of USC, Los Angeles
LAC + USC Medical Center, Los Angeles
他2件

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Southern California Research Center, Coronado
Om Research Llc, Lancaster
Clinnova Research Solutions, Orange
他3件

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

San Fernando Valley Health Institute, Canoga Park
Ark Clinical Research - Fountain Valley, Fountain Valley
Fresno Clinical Research Center, Fresno
他11件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site, Coronado
Akero Clinical Study Site, Escondido
Akero Clinical Study Site, Folsom
他13件

被験者募集中第3相

18歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site, Arcadia
GSK Investigational Site, Covina
GSK Investigational Site, Los Angeles
他3件

被験者募集中第3相

18歳〜75歳 · 全性別 · 2026/09/17更新 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Om Research, Apple Valley
ARK Clinical Research - Fountain Valley, Fountain Valley
UCSD Medical Center, La Jolla
他4件

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/09更新 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

89bio Clinical Study Site, Canoga Park
89bio Clinical Study Site, Coronado
89bio Clinical Study Site, Escondido
他13件

被験者募集中第3相

18歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio Clinical Study Site, Camarillo
89bio Clinical Study Site, Canoga Park
89bio Clinical Study Site, Coronado
他10件

被験者募集中第3相

18歳〜75歳 · 全性別 · 2026/09/03更新 · NCT06419374

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

GSK Investigational Site, Coronado
GSK Investigational Site, Lancaster
GSK Investigational Site, Los Angeles
他3件

被験者募集中第2相

18歳〜70歳 · 全性別 · 2026/08/03更新 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site, Arcadia
GSK Investigational Site, Covina
GSK Investigational Site, Folsom
他6件

被験者募集中第3相

18歳〜75歳 · 全性別 · 2026/07/27更新 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

GSK Investigational Site, Fresno
GSK Investigational Site, Lancaster
GSK Investigational Site, Pasadena
他2件

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/07/08更新 · NCT06920043

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

GSK Investigational Site, Rialto

被験者募集中第1相

18歳〜70歳 · 全性別 · 2026/06/09更新 · NCT07358546

Bicalutamide Therapy in Young Women With NAFLD and PCOS

University of California San Francisco, San Francisco

被験者募集中第1相

18歳〜42歳 · 女性 · 2026/05/29更新 · NCT05979389

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Velocity Clinical research, Los Angeles

被験者募集中第1/2相健康なボランティア歓迎

18歳〜75歳 · 全性別 · 2026/04/16更新 · NCT05648214

Androgens and NAFLD Longitudinal Cohort Study

University of California San Francisco, San Francisco

被験者募集中観察研究

18歳〜42歳 · 女性 · 2026/04/13更新 · NCT06124261

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

University of California San Diego, La Jolla

被験者募集中観察研究

18歳以上 · 全性別 · 2026/04/09更新 · NCT07518784

Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

University of California San Diego, La Jolla

被験者募集中観察研究

9歳〜18歳 · 全性別 · 2026/01/21更新 · NCT06706856

Implementing Food Referrals for Equity and Sustained Health

Rady Children's Hospital San Diego, San Diego

被験者募集中第2相健康なボランティア歓迎

5歳以上 · 全性別 · 2025/11/19更新 · NCT06661538

Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

Stanford University, Stanford

被験者募集中健康なボランティア歓迎

35歳〜65歳 · 全性別 · 2024/12/04更新 · NCT05165706

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。